25 results
8-K
EX-3.1
RVNC
Revance Therapeutics Inc
15 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:04pm
. Organization
ARTICLE V OFFICERS
Section 28. Officers Designated
Section 29. Tenure And Duties Of Officers.
Section 30. Delegation Of Authority
Section 31 … be fixed by or in the manner designated by the Board of Directors.
Section 29. Tenure And Duties Of Officers.
(a) General. All officers shall hold
8-K
EX-3.1
RVNC
Revance Therapeutics Inc
22 Dec 21
Amendments to Articles of Incorporation or Bylaws
4:01pm
.
Section 27. Organization.
ARTICLE V OFFICERS
Section 28. Officers Designated.
Section 29. Tenure And Duties Of Officers.
Section 30. Delegation … be fixed by or in the manner designated by the Board of Directors.
Section 29. Tenure And Duties Of Officers.
(a) General. All officers shall hold office
PRE 14A
pm5t4s1t5zpi11gd
12 Mar 21
Preliminary proxy
4:13pm
8-K
jr8eucx pc4yv4t9723
22 Feb 21
Revance Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm
8-K
EX-99.1
a9yxo44zn8ylm7j4
22 Feb 21
Revance Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm
8-K
EX-99.2
hwurmon fvc
22 Feb 21
Revance Reports Fourth Quarter and Full Year 2020 Financial Results
4:06pm
8-K
EX-99.1
16dvxgu
15 Oct 19
Revance Appoints Mark J. Foley as President and CEO, Replacing Dan Browne
8:17am
10-K
rie50ktdussy5vryjk
28 Mar 14
Annual report
12:00am
424B4
bb5a3n wpp
6 Feb 14
Prospectus supplement with pricing info
12:00am
S-1
EX-3.3
n6iuoig9uoc m1
31 Dec 13
IPO registration
12:00am
S-1
7pjf7zw30yl
31 Dec 13
IPO registration
12:00am